Kevin Pojasek
Oprichter bij Catamaran Bio, Inc.
Profiel
Kevin Pojasek was the founder of Quartet Medicine, Inc. (founded in 2013) where he served as President & Chief Executive Officer from 2013 to 2015.
He is also the founder of Catamaran Bio, Inc. Dr. Pojasek's current job(s) include being the President, CEO & Director at Enara Bio Ltd.
since 2018 and a Venture Partner at SV Health Investors LLP since 2018.
Dr. Pojasek's former job(s) include being a Director-Development Projects at Solace Pharmaceuticals, Inc., a Board Director at Amathus Therapeutics, Inc. from 2018 to 2021, a Principal at Momenta Pharmaceuticals, Inc., a Principal at KALA BIO, Inc., the Chief Operating Officer at Annovation BioPharma, Inc., an Entrepreneur-in-Residence at Atlas Venture Advisors, Inc., a Senior Associate at Puretech Health LLC, and the Chief Strategy and Business Officer at Immunocore Ltd.
from 2016 to 2018.
Dr. Pojasek's education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from The University of Colorado.
Dr. Pojasek is also the founder of Catamaran Bio, Inc...
Actieve functies van Kevin Pojasek
| Bedrijven | Functie | Begin |
|---|---|---|
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Oprichter | - |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | 01-09-2018 |
| Enara Bio Ltd. | Algemeen Directeur | 01-09-2018 |
Eerdere bekende functies van Kevin Pojasek
| Bedrijven | Functie | Einde |
|---|---|---|
Amathus Therapeutics, Inc.
 Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-12-2021 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Corporate Officer/Principal | 01-05-2018 |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Quartet Medicine, Inc. is a biotechnology company that develops treatments for chronic pain and inflammation by restoring tetrahydrobiopterin homeostasis inneuronal and inflammatory cells. Its drug discovery efforts are fully structurally enabled and are focused on demonstrating changes in BH4-related biomarkers that correlate with drug pharmacokinetics and efficacy in preclinical animal models. The company was founded by Kevin Pojasek, Kai Johnsson, and Clifford Woolf in 2013 and is headquartered in Cambridge, MA. | Oprichter | - |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Operationeel Directeur | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Opleiding van Kevin Pojasek
| Massachusetts Institute of Technology | Doctorate Degree |
| The University of Colorado | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Solace Pharmaceuticals, Inc.
 Solace Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solace Pharmaceuticals, Inc. develops therapies for the treatment of neuropathic pain. It offers therapies for neuropathic and inflammatory pain. It offers discovery and development of innovative therapies for pain through in-house drug discovery and development programs as well as through selected partnerships. The company was founded in March 2006 by Allan Basbaum, Bruce Bean, Joyce Deleo and Tony Yaksh and is headquartered in Boston, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Quartet Medicine, Inc.
Quartet Medicine, Inc. BiotechnologyHealth Technology Quartet Medicine, Inc. is a biotechnology company that develops treatments for chronic pain and inflammation by restoring tetrahydrobiopterin homeostasis inneuronal and inflammatory cells. Its drug discovery efforts are fully structurally enabled and are focused on demonstrating changes in BH4-related biomarkers that correlate with drug pharmacokinetics and efficacy in preclinical animal models. The company was founded by Kevin Pojasek, Kai Johnsson, and Clifford Woolf in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Health Technology |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Finance |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
| Enara Bio Ltd. | Health Technology |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Finance |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
